This month we are featuring Dr. Arunkanth Ankala, Genomics Director at EGL. Dr. Ankala is Board Certified in Clinical Molecular Genetics. Dr. Ankala has a PhD in Molecular Biology, from Mississippi State University and M.Sc in Biochemistry from Bharatidasan University, India. Dr. Ankala completed his post-graduate training at Emory University School of Medicine. He has been working at EGL (formerly Emory Genetics Laboratory) since 2014 as a Molecular Genetics Director.
Arun has published over 30 peer-reviewed publications that include research papers, review articles, editorials and book chapters. He has also served as an editor for a book on Muscular Dystrophy (ISBN: 978-953-51-0603-6). He has presented at several meetings on current topics such as ‘Implementation and clinical utility of transcriptome sequencing: Experience from neuromuscular disorders’ at American College of Medical Genetics 2016 Meeting. He serves as reviewer for several journals such as Neurology, Neurology Genetics, Genes, Human Mutation and Genetics in Medicine.
Dr. Ankala’s primary clinical research has been the application of exome sequencing technology to molecular diagnosis and the evaluation of its true diagnostic potential. With a thorough understanding of the limitations and potentials of the technology, his research focus lies in developing a more customized, curated and complete next generation sequencing assay. His broader research interest has been the discovery of new disease causing genes associated with different muscular dystrophies and understanding the genotype-phenotype correlation for the variety of known muscular dystrophies.
To learn more about his research and experience in neuromuscular disorder testing, meet him at American Society of Human Genetics Conference 2018, San Diego, CA. Or stop by our booth 1010.